首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 78 毫秒
1.
新型噻唑并[3,2-a]嘧啶类化合物的合成   总被引:1,自引:0,他引:1  
5-乙氧羰基-4-芳基-6-甲基-3,4-二氢嘧啶-2-酮与丁炔二酸二甲酯反应, 合成了系列新的噻唑并[3,2-a]嘧啶类化合物, 反应具有时间短、收率高、后处理简单等优点. 采用NMR (1H, 13C, COSY, HSQC和HMBC), IR等多种谱学技术, 结合元素分析对产物进行详细表征, 通过对目标产物的1,3-偶极环加成的衍生化产物进行X射线单晶衍射而确定目标产物的结构.  相似文献   

2.
以芳醛为起始原料,与硫脲和乙酰乙酸乙酯利用Biginelli反应先合成二氢嘧啶类化合物后,再与取代的溴代苯乙酮经Hantzsch环合反应,最后烷基化得到目标化合物3a-3h。化合物结构经1 H NMR、13 C NMR、IR 和HRMS确证。初步抗肿瘤活性测试结果表明,部分化合物的抗肿瘤活性与对照药物相当  相似文献   

3.
以取代苯肼盐酸盐为原料,通过Vilsmeier-Haack,Biginelli和Knoevenagel等多步反应合成了9个含有吡唑取代基的噻唑并[3,2-a]嘧啶衍生物,并利用IR,1H NMR,13C NMR,ESI-MS和HRMS对目标化合物进行了结构表征.用四甲基偶氮唑盐(MTT)法测试了目标产物对人前列腺癌PC-3细胞和人肝癌Hep G2细胞的体外抗增殖活性,部分化合物表现出了较好的生物活性,其中化合物5b,5c,5g和5i对PC-3细胞的抗肿瘤活性优于阳性对照药5-氟尿嘧啶,IC50值分别为29.98,27.69,26.36和12.56μmol/L.进一步的研究表明,化合物5i能够诱导PC-3细胞凋亡,并使其周期阻滞在G2/M期.  相似文献   

4.
通过7-芳亚甲基-6,7-二氢中氮茚-8(5H)-酮与甲亚胺叶立德(经苊醌或靛红与肌氨酸反应原位生成)进行的l,3-偶极环加成反应,合成了具有良好产率的新的1’-甲基-4’-芳基-5",6"-二氢-2H,8"H-二螺[苊烯-1,2’-吡咯烷-3’,7"-中氮茚]-2,8"-二酮类化合物和1’-甲基-4’-芳基-5",6"-二氢-1H,8"H-二螺[吲哚-3,2’-吡咯烷-3’,7"-中氮茚]-2,8"-二酮类化合物.采用NMR,IR,质谱,元素分析以及X射线单晶衍射等多种谱学技术对产物进行了结构表征.  相似文献   

5.
以芳醛、硫脲等为起始原料,通过Biginelli反应合成二氢嘧啶类化合物,再与取代的溴代苯乙酮发生Hantzsch环合反应得到目标化合物。所有化合物的结构都经过1H NMR、13C NMR、IR和HRMS表征确认。在此基础上以MCF-7、A549和HT-29为靶细胞,顺铂为阳性对照物,采用噻唑蓝检测法进行初步体外抗肿瘤活性筛选。结果表明,化合物3c对HT-29的体外抗肿瘤活性与对照药物相当,值得进一步研究。  相似文献   

6.
通过2-芳亚甲基-2,3-二氢-1H-吡里-1-酮与腈亚胺[经苯甲酰氯苯腙(2)与三乙胺反应生成]的1,3-偶极环加成反应,以较高收率合成了一系列的4-芳基-2,5-二苯基-2H,4H-二氢-螺[吡唑-3,2’-吡咯里嗪]-1’(3’H)-酮.采用NMR,IR,质谱和元素分析等多种谱学技术对产物进行了结构表征.  相似文献   

7.
α-四氢萘酮的乙氧羰基腙(1)经LTA氧化, 得到α-偶氮-α-乙酰氧基化合物2. 在AlCl3作用下, 化合物2脱去乙酰氧基产生重氮正离子中间体3, 再经与腈的1,3-偶极环加成、 [1,2]-迁移扩环、碱性水解和与苦味酸作用, 得到新型[1,2,4]-三唑并[1,5-a][1]苯并氮杂(艹卓)苦味酸盐6a~6c. 以2,3-二氢-1-茚酮为底物, 采用相同的合成路线, 合成了1,2,4-三唑并[1,5-a]-二氢喹啉苦味酸盐12a~12c.  相似文献   

8.
利用生物电子等排原理和生物活性基团拼接原理,设计合成了 16个7-苯基-6H,7H-1,3,4-噻二唑并[3,2-a]-硫色烯并[4,3-d]嘧啶类化合物.目标化合物均经核磁共振氢谱(1HNMR)、核磁共振碳谱(13C NMR)和高分辨质谱仪(HRMS)进行了结构确证.体外抗真菌活性结果表明,对于动物病原菌,化合物对总...  相似文献   

9.
利用微波促进氮杂糖硝酮(2)与丙烯酸类衍生物(3)发生1,3-偶极环加成反应,立体选择性地得到了一系列新的含异噁唑烷的氮杂糖衍生物(4),反应效率显著提高,反应时间由95h缩短为5~15min,收率由67%提高到78%~88%.利用NMR和HRMS等方法结合化合物(4d-1)的单晶结构确定了产物的结构和相对构型.  相似文献   

10.
11.
The 1,3‐dipolar cycloaddition of an azomethine ylide generated by a decarboxylative route from sarcosine and acenaphthenequinone to 7‐arylmethylidene‐3‐aryl‐3,4‐dihydro‐2H‐thiazolo[3,2‐a][1,3,5]triazin‐6(7H)‐ones afforded novel dispiro[acenaphthylene‐1,2′‐pyrrolidine]‐3′,7′ ′‐[1,3]thiazolo[3,2‐a][1,3,5]triazines in moderate yields. The structures of the products were determined and characterized thoroughly by NMR, MS, IR, elemental analysis and X‐ray crystallographic analysis. The results of experiment indicated that this 1,3‐dipolar cycloaddition proceeded with high stereoselectivity and regioselectivity.  相似文献   

12.
In a one-pot synthesis, 1′-methyl-2,3″-dioxo-5″-aryl-1,2,5a″,7″,8″,9a″-hexahydro-5″H,6″H-dispiro[indole-3,2′-pyrrolidine-3′,2″-pyrano[2,3-d][1,3]thiazolo[3,2-a]pyrimidine]-4′-carboxylic acid methyl ester was prepared via the sequential reaction of 4-aryl-octahydro-pyrano[2,3-d]pyrimidine-2-thione, dimethyl acetylenedicarboxylate (DMAD), and a mixture of isatin and sarcosine. All the novel spiro compounds, in moderate yields, were characterized thoroughly by infrared, NMR, mass spectromentry, and elemental analysis together with x-ray crystallographic analysis.  相似文献   

13.
The functionalized 1,10-dihydropyrrolo[1,2-a][1,10]phenanthroline derivatives were synthesized in good yields and with high diastereoselectivity by 1,3-dipolar cycloaddition reactions of N-phenacylphenanthrolinium bromides or N-ethoxycarbonylmethylene phenanthrolinium bromide with various nitrostyrenes in acetonitrile at room temperature in the presence of triethvlamine,  相似文献   

14.
A new class of [1,2,4]oxadiazolo[4,5‐a]thiazolo[2,3‐b]pyrimidin‐9(10H)‐one was prepared in moderate yields by the reaction of nitrile oxide with 2‐arylmethylidene‐6,7‐dihydro‐5H‐thiazolo[3,2‐a]pyrimidin‐3‐one. The reaction site of dipolarphile is the C?N of thiazolo[3,2‐a]pyrimidin‐3‐one rather than the expected C?C of arylmethylidene. The structures of the products were characterized thoroughly by IR, elemental analysis, MS, and NMR analysis.  相似文献   

15.
The 1,3‐dipolar cycloaddition reactions of nitrilimine with thiazolo[3,2‐a]pyrimidine derivatives was investigated. Bis‐cycloadducts were obtained through a domino 1,3‐dipolar cycloaddition/ring‐opening/ring‐opening/1,3‐dipolar cycloaddition processes. The structures of the products were characterized thoroughly by NMR, IR, MS, elemental analysis together with X‐ray crystallographic analysis.  相似文献   

16.
The sulfides formed by the reaction of α-halo ketones or α-halo acetals with 2-mercaptopyridine may be cyclized in good yield to form thiazolo[3, 2-a]pyridinium salts. The presence of chloro or nitro substituents on the pyridine ring does not interfere with the synthesis. Nitration of 3-methylthiazolo[3, 2-a]pyridinium perchlorate has been found to occur at position 8.  相似文献   

17.
以3-甲基-1-苯基-2-吡唑啉-5-酮为原料,经Vilsmeier-Haack反应和Biginelli反应制得4-(5-氯-3-甲基-1-苯基-唑-4-基)-5-甲酸乙酯-6-甲基-3,4-二氢嘧啶-2(1H)-硫酮(3);3与芳醛经Knoevenagel反应合成了5个新型的含吡唑的噻唑[3,2-a]并嘧啶类化合物(5a~5e),其结构经1H NMR,13C NMR,IR和ESI-MS表征。采用MTT法测定了5a~5e的抗肿瘤活性。结果表明:5a~5e对人前列腺癌PC-3细胞均具有一定的体外抗增殖活性,其中2-【4-{[6-(乙氧羰酯)-5-(5-氯-3-甲基-1-苯基-吡唑-4-基)-3-氧代-7-甲基-噻唑并[3,2-a]嘧啶-2(5H)-亚基]甲基}苯氧基】乙酸(5a)活性最强,其IC50为44.45μM。  相似文献   

18.
From the alkali-catalysed reaction of thiouracil with bromoacetaldehyde diethyl acetal three products are isolated in nearly the same quantity: 2-(2, 2-diethoxyethylthio)-uracil ( 2 ) and two cyclization products: 3 , a thiazolo[3, 2-a]pyrimidin-5-one, and 4 , athiazolo[3, 2-a]pyrimidin7-one. By warming with acid both 2 and 4 yield 3 . Rearrangement of 4 to 3 proceeds also by heating the hydrochloride. Similar cyclizations leading to thiazolo[3, 2-d]pyrrolo[2, 3-d]pyrimidin-5-ones are also described. Bromine substitutes 3 in position 6. The bromo derivative 6 on treatment with primary or secondary amines affords 7-amino compounds.  相似文献   

19.
Russian Journal of Organic Chemistry - Three-component 1,3-dipolar cycloaddition reactions between isatin, benzylamine, and α,β-unsaturated ketones at room temperature afforded...  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号